CD38 and chronic myelogenous leukemia, BCR-ABL1 positive: In this study, we conducted a comprehensive analysis of the expression patterns of CD56 and CD38 on neutrophils in CML and demonstrated that the increased proportion of CD56briCD38+ neutrophil subsets can serve as a specific marker for rapid and accurate recognition of CML using flow cytometry.